Search results
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 2 days agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 2 days agoPfizer (PFE) beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 day agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Naviter Wealth LLC Sells 3,036 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoNaviter Wealth LLC trimmed its position in Pfizer Inc. (NYSE:PFE – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent disclosure with the ...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 2 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 2 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 2 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via AOL· 2 days agoOn Wednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...